Hims & Hers Completes Acquisition of Eucalyptus, Advancing Position as the World's Largest Consumer Health Platform

Go back to Hims & Hers Completes Acquisition of Eucalyptus, Advancing Position as the World's Largest Consumer Health Platform

Leerink Reiterates Market Perform Rating on Hims and Hers (HIMS)

June 2, 2026 8:19 AM EDT

Leerink analyst Michael Cherny reiterated a Market Perform rating and $25.00 price target on Hims and Hers (NYSE: HIMS).

The analyst comments "We are updating our HIMS estimates to reflect today's completion of the Eucalyptus acquisition and recent financing that is partially funding... More